The New K Variant Flu Strain, Holiday Gatherings, and What You Should Do Right Now

As we head into Christmas week, many of you are traveling, hosting family, or attending large gatherings. I want to briefly address the new circulating flu strain—commonly referred to in the media as the “K variant,” and medically classified as Influenza A (H3N2)—that we are seeing this season, and more importantly, what it means practically for you and your family over the next 10 days.

---

What’s different about this flu season?

The term “K variant” refers to a subclade within Influenza A (H3N2) identified by internal genetic naming (often beginning with letters or numbers used by virologists).

Influenza viruses change every year, but this season we are seeing a strain with several characteristics that are worth noting:

• Higher transmissibility: This strain appears to spread more efficiently, particularly in indoor, close-contact settings such as family gatherings and travel.

• Faster onset of symptoms: Many patients report feeling well then significantly ill a few hours later, with sudden fever, body aches, headache, and fatigue.

• Higher likelihood of spreading before isolation: Because symptoms escalate quickly, people may unknowingly expose others in the early phase.

---

Is the current flu vaccine effective?

Based on early-season data and what we know about this specific H3N2 lineage, effectiveness against the K variant appears to be roughly 30% for preventing symptomatic infection.

Here is the nuance that matters:

• For Influenza A (H3N2) specifically, vaccine effectiveness in most seasons ranges from 20–50%, depending on how well the vaccine matches the circulating strain.

• H3N2 strains historically have lower vaccine effectiveness than other flu strains because they mutate more rapidly.

• Despite its relatively low effectiveness against this infection, the CDC continues to recommend the flu vaccine because it seems to reduce the risk of severe illness.

---

Why is effectiveness lower this year?

One key reason is timing. The WHO finalized the strain selection for the 2026–2027 flu vaccine in February 2025. The K variant was first reported in surveillance data in the spring (around April) in East Asia, just a couple of months after vaccine production decisions had already been locked in.

---

Why Holiday gatherings increase risk

From a medical standpoint, holidays are the perfect storm for viral spread:

• Prolonged indoor exposure

• Large, multi-generational gatherings

• Travel fatigue, poor sleep, and dietary excess

• Cold weather driving everyone indoors

Even healthy individuals can become efficient carriers, often spreading the virus before realizing they are sick.

---

Practical, common-sense steps for the next 10 days

1. Do not “power through” symptoms. If you feel achy, feverish, unusually fatigued, or develop a sore throat or cough, please stay home. This protects everyone, including you. If you are mildly ill but must attend a gathering for an unavoidable reason, I recommend wearing a mask to reduce the risk of spreading infection.

2. Prioritize sleep this week. Sleep deprivation is one of the fastest ways to suppress immune function. Aim for consistency, even during travel.

3. Limit alcohol and sugar. Both temporarily impair immune response. Moderation matters more this week than most.

4. Wash hands and surfaces. This remains one of the most effective interventions we have.

5. Reach out early if you get sick. As concierge members, you have early access to me. If you develop flu-like symptoms, please reach out as soon as possible. Antiviral medications are most effective when started within 48 hours of symptom onset.

The FDA-approved antiviral medications I commonly use include:

• Oseltamivir (Tamiflu®)

• Baloxavir marboxil (Xofluza®)

• Zanamivir (Relenza®)

Early treatment can shorten illness duration and reduce the risk of complications, especially in higher-risk patients.

I also recommend purchasing at-home flu tests now from your local pharmacy. These tests may become harder to find later in the week, and having them on hand allows for faster decision-making if symptoms start.

---

Supplements and nutrients that may reduce infection risk

Several nutrients have evidence suggesting they may support immune function and modestly reduce the risk or severity of respiratory infections.

• Vitamin D: Low vitamin D levels are consistently associated with increased risk of respiratory infections. Most of my patients are already on vitamin D, and I routinely check levels to make sure the dose is appropriate. This is simply a reminder to keep taking it consistently, especially during the winter months.

• Zinc: Zinc plays a key role in antiviral immunity. I typically recommend 30–50 mg of zinc daily during periods of increased infection risk or early illness. If zinc is taken for more than a couple of weeks, it should be paired with 2 mg of copper daily, as prolonged zinc supplementation can lead to copper deficiency.

• Vitamin C: I typically recommend 1,000–2,000 mg daily, as long as it does not cause stomach upset. When taking vitamin C at these doses, it is important to stay well hydrated to reduce the risk of vitamin C–related kidney stones. As a general guideline, I recommend aiming for at least 2–3 liters (about 70–100 ounces) of water per day, unless you have been advised otherwise for medical reasons.

• Elderberry (Sambucus nigra): Some studies suggest elderberry may reduce duration and severity of influenza-like illness when taken early. A typical adult dose is at least 200 mg per day.

• Inulin (a prebiotic fiber): Inulin does not act directly on viruses, but by nourishing beneficial gut bacteria, it indirectly supports immune function. Emerging evidence suggests that prebiotic fibers like inulin can improve gut barrier integrity and enhance immune signaling, which may modestly reduce susceptibility to respiratory infections.

• Iota-carrageenan (nasal spray): Iota-carrageenan has been studied as a topical antiviral agent when used intranasally. It works by forming a physical barrier on the nasal mucosa that can bind respiratory viruses and reduce their ability to infect cells. Several randomized trials suggest it may reduce viral load, symptom severity, and duration when used early in the course of influenza-like illnesses. It is not systemic and does not stimulate the immune system. I often recommend it preventively before higher-risk exposures, such as large gatherings, airports, airplane travel, or other crowded indoor settings.

• Quercetin: Quercetin is a plant-derived flavonoid with anti-inflammatory and antioxidant properties. In laboratory and early clinical studies, it has shown potential antiviral effects and may help modulate immune responses. Some evidence suggests it may reduce the incidence or duration of upper respiratory infections. A typical dose is 250-500 mg per day.

I recommend starting these supplements now, rather than waiting until symptoms develop, so that by the time holiday gatherings arrive your body has had time to reach adequate, steady levels that may provide better protection.

---

My bottom line

Enjoy the holidays. Spend time with your family. Celebrate.

Just do it wisely, listen to your body, and be respectful of symptoms—yours and others’. A little caution now can prevent a lot of problems in January.

As always, if you have questions or concerns, or if symptoms arise, reach out to the office.

---

To Your Good Health,

The Longevity Doctor®